ClearPoint Neuro
Stock Forecast, Prediction & Price Target
ClearPoint Neuro Financial Estimates
ClearPoint Neuro Revenue Estimates
ClearPoint Neuro EBITDA Estimates
ClearPoint Neuro Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | ||
Revenue
% change YoY
| $16.29M N/A | $20.55M 26.08% | $23.95M 16.56% | Avg: $42.21M Low: $41.37M High: $43.06M avg. 76.24% | Avg: $58.3M Low: $53.97M High: $61.33M avg. 38.08% | ||
Net Income
% change YoY
| $-15.32M N/A | $-16.53M -7.95% | $-22.08M -33.56% | Avg: $-16.51M Low: $-16.97M High: $-13.28M avg. 25.22% | Avg: $-15.1M Low: $-14.44M High: $-12.22M avg. 8.57% | ||
EBITDA
% change YoY
| $-12.74M N/A | $-15.57M -22.22% | $-20.98M -34.74% | Avg: $-26.81M Low: $-27.35M High: $-26.27M avg. -27.74% | Avg: $-37.02M Low: $-38.95M High: $-34.28M avg. -38.08% | ||
EPS
% change YoY
| -$0.74 N/A | -$0.68 8.10% | -$0.9 -32.35% | Avg: -$0.62 Low: -$0.69 High: -$0.54 avg. 31.11% | Avg: -$0.55 Low: -$0.59 High: -$0.5 avg. 11.29% | ||
Operating Expenses
% change YoY
| $24.66M N/A | $29.86M 21.07% | $36.06M 20.75% | Avg: $38.32M Low: $37.56M High: $39.09M avg. 6.29% | Avg: $52.92M Low: $49.00M High: $55.68M avg. 38.08% | ||
FAQ
What is ClearPoint Neuro stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 16.90% in 2025-2026.
We have gathered data from 2 analysts. Their low estimate is -16.97M, average is -16.51M and high is -13.28M.
What is ClearPoint Neuro stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 57.16% in 2025-2026.
We have gathered data from 2 analysts. Their low revenue estimate is $41.37M, average is $42.21M and high is $43.06M.
What is ClearPoint Neuro stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 21.20% in 2025-2026.
We have gathered data from 2 analysts. Their low earnings per share estimate is -$0.69, average is -$0.62 and high is $-0.54.
What is the best performing analyst?
In the last twelve months analysts have been covering ClearPoint Neuro stock. The most successful analyst is Mathew Blackman.